55 A new study conducted by a team of international researchers has led to the development of a novel nanofibre scaffold that holds promise for both bone cancer treatment and the regeneration of damaged bone tissue. This new material, which is made up of polydopamine (PDA)-coated gold nanoparticles and polycaprolactone (PCL) nanofibers, shows a lot of promise for making bone cancer treatments work better and helping bones grow back faster. The findings were published in the journal Materials Today Nano. Bone cancer remains a severe medical challenge, often necessitating aggressive treatments such as surgery, chemotherapy, or radiation therapy. However, these conventional treatments come with considerable drawbacks, including extensive side effects, high costs, and limited effectiveness in completely eradicating cancerous cells. Moreover, these methods often leave patients with substantial bone defects that are difficult to heal, further complicating recovery and reducing the quality of life. In this context, the development of nanotechnology-based treatments offers a promising alternative. The researchers focused on the potential of photothermal therapy (PTT), a technique that uses light to generate heat capable of destroying cancer cells without damaging surrounding healthy tissue. PTT’s non-invasive nature and precision make it an attractive option for treating cancers located in delicate areas, such as bone tissues. The study, which involved researchers from Jeonbuk National University in South Korea and Newcastle University in the UK, sought to overcome the limitations of current bone cancer treatments by designing a bifunctional material. This material not only targets and destroys cancer cells but also supports the regeneration of bone tissue. The researchers achieved this by integrating gold nanospheres (GNSs) coated with PDA into a PCL-based nanofibre scaffold. Gold nanoparticles are well-known for their excellent electrical conductivity, optical properties, and biocompatibility, making them suitable for medical applications. However, their effectiveness is further enhanced when coated with PDA, a bioinspired polymer that improves the nanoparticles’ stability and photothermal efficiency. The resulting PCL-GNSs@PDA nanofibre scaffold exhibited remarkable properties, including enhanced mechanical strength, elasticity, and a higher surface area compared to pure PCL nanofibres. These attributes are crucial for ensuring the scaffold’s effectiveness in both cancer ablation and bone regeneration. One of the study’s most notable findings was the scaffold’s ability to induce significant cancer cell death under near-infrared (NIR) light irradiation. The PCL-GNSs@PDA scaffold, particularly at a concentration of 5.0 mg of GNSs@PDA, demonstrated a high photothermal conversion efficiency, leading to the ablation of 94% of bone cancer cells (MG-63) after just five minutes of exposure to low-power NIR light. This high rate of cancer cell destruction was accompanied by an increase in apoptosis (programmed cell death) among the cancer cells, suggesting that the scaffold effectively triggers the cellular mechanisms needed to combat bone cancer. The scaffold’s photothermal stability, tested over multiple cycles, further confirmed its potential as a reliable tool for bone cancer therapy. Beyond its anti-cancer capabilities, the PCL-GNSs@PDA scaffold also showed promising results in promoting bone tissue regeneration. The scaffold provided an optimal environment for the proliferation and differentiation of bone-forming cells (MC3T3-E1), leading to the formation of mineralised bone tissue over 21 days. This indicates that the scaffold could be instrumental in repairing bone defects caused by cancer or its treatment, thus addressing a critical gap in current therapeutic approaches. The study’s findings represent a significant advancement in the field of bone cancer therapy and tissue engineering. By combining the benefits of photothermal therapy with the regenerative properties of a bioinspired nanofibre scaffold, the researchers have developed a material that could potentially revolutionise the treatment of bone cancer and improve the quality of life for affected patients. While the results are promising, further research and clinical trials are necessary to fully understand the scaffold’s long-term effects and safety in human applications. If successful, this dual-action nanofibre scaffold could pave the way for new, less invasive treatments that not only eliminate cancerous cells but also support the healing and regeneration of affected tissues.